Homeopathy for Perennial Asthma in Adolescents: Pilot Feasibility Study Testing a Randomised Withdrawal Design

Abstract

Introduction Previous findings from a pragmatic trial suggest that usual care compared with usual care plus individualised homeopathy is not a feasible design to address homeopathic interventions for asthma.

Objective The main purpose of this article was to investigate the feasibility of the randomised withdrawal design as a strategy to assess the effectiveness of a standardised clinical–pharmaceutical homeopathic protocol (Organon.modus) on perennial asthma in adolescents.

Methods Randomised withdrawal, double-blind, parallel, placebo-controlled, 12-week study. Patients: 12 to 17 years old adolescents, with the diagnosis of perennial asthma, using inhalatory beclomethasone (plus fenoterol for wheezing episodes), who achieved 3 months of well-controlled asthma, after a variable period of individualised homeopathic treatment according to Organon.modus protocol. Setting: a secondary care medical specialist centre. Intervention: continuation with the individualised homeopathic medicine or with indistinguishable placebo during 12 weeks of beclomethasone step-down. Primary outcome: number of days of well-controlled asthma. Secondary measures: number of days of fenoterol use, number of visits to an emergency service (without hospitalisation) and percentage of patients excluded due to an exacerbation characterising a partly controlled asthma. Tolerability was assessed by Adverse Events, registered at every visit.

Results Nineteen patients were randomised to continue treatment with homeopathy and 21 with placebo. Effectiveness measures for the homeopathy and placebo groups respectively were median number of days of good clinical control: 84 versus 30 (p = 0.18); median number of days of fenoterol use per patient: 3 versus 5 (p = 0.41); visits to an emergency room: 1 versus 6 (p = 0.35); percentage of exclusion due to partly controlled asthma: 36.8% versus 71.4% (p = 0.05). Few Adverse Events were reported.

Conclusions This pilot study supports the feasibility of the double-blind randomised withdrawal design in studies investigating homeopathy on teenage asthma, when performed by specialists following a standardised clinical–pharmaceutical homeopathic protocol.

Clinical Trial Registration RBR-6XTS8Z.

Keywords

perennial asthma - beclomethasone - homeopathy

• References

• 1 Hossny E, Rosario N, Lee BW. , et al. The use of inhaled corticosteroids in pediatric asthma: update. World Allergy Organ J 2016; 9: 26
• 2 Misra SM. The current evidence of integrative approaches to pediatric asthma. Curr Probl Pediatr Adolesc Health Care 2016; 46: 190-194
• 3 BRASIL. Ministério da Saúde. Portaria GM n° 971 de 03 de maio de 2006. Available at: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2006/prt0971_03_05_2006.html . Accessed July 21, 2017
• 4 Adler UC, Cesar AT, Adler MS, Padula AE, Garozzo EN, Galhardi WP. From pharmaceutical standardizing to clinical research: 20 years of experience with fifty-millesimal potencies. Int J High Dilution Res 2009; 8: 173-182 Available at: http://highdilution.org/index.php/ijhdr/article/view/367 . Accessed March 01, 2018
• 5 Thompson EA, Shaw A, Nichol J. , et al. The feasibility of a pragmatic randomised controlled trial to compare usual care with usual care plus individualised homeopathy, in children requiring secondary care for asthma. Homeopathy 2011; 100: 122-130
• 6 U.S. Department of Health and Human Services Food and Drug Administration. Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products. Draft Guidance for Industry, 2012. Available at: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM332181.pdf. . Accessed February 5, 2018
• 7 Global Strategy for Asthma Management and Prevention. Update 2017. Available at: www.ginasthma.org . Accessed February 5, 2018
• 8 Hahnemann S. Organon der Heilkunst 6. Auflage. Leipsig: Schwabe;1921 - Heidelberg: Haug; 1992
• 9 Haynes W. Wilcoxon rank sum test. In: Dubitzky W, Wolkenhauer O, Cho KH, Yokota H. , eds. Reference Work Entry: Encyclopedia of Systems Biology. New York, NY: Springer; 2013
• 10 Wilcox RR. A review of the beta-binomial model and its extensions. J Educ Behav Stat 1981; 6: 3-32
• 11 Perera BJ. Successful withdrawal of inhaled corticosteroids in childhood asthma. Respirology 2005; 10: 385-388
• 12 White A, Slade P, Hunt C, Hart A, Ernst E. Individualised homeopathy as an adjunct in the treatment of childhood asthma: a randomised placebo controlled trial. Thorax 2003; 58: 317-321
• 13 Dantas F. Comment on individualised homeopathy as an adjunct in the treatment of childhood asthma: a randomised placebo controlled trial. Thorax 2003; 58: 826 , author reply 828
• 14 Fisher P, Chatfield K, Mathie R. Comment on individualised homeopathy as an adjunct in the treatment of childhood asthma: a randomised placebo controlled trial. Thorax 2003; 58: 827 , author reply 828
• 15 Borges S, Chen YF, Laughren TP. , et al. Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration. J Clin Psychiatry 2014; 75: 205-214
• 16 Galvao TF, Zimmermann IR, da Mota LM, Silva MT, Pereira MG. Withdrawal of biologic agents in rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol 2016; 35: 1659-1668
• 17 Hnin K, Nguyen C, Carson KV, Evans DJ, Greenstone M, Smith BJ. Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults. Cochrane Database Syst Rev 2015; CD001392
• 18 Buitelaar J, Asherson P, Soutullo C. , et al. Differences in maintenance of response upon discontinuation across medication treatments in attention-deficit/hyperactivity disorder. Eur Neuropsychopharmacol 2015; 25: 1611-1621
• 19 Frei H, Everts R, von Ammon K. , et al. Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial. Eur J Pediatr 2005; 164: 758-767
• 20 Anderson SF, Kelley K, Maxwell SE. Sample-size planning for more accurate statistical power: a method adjusting sample effect sizes for publication bias and uncertainty. Psychol Sci 2017; 28: 1547-1562